The regularities of the time course and intracellular distribution of estrogen receptors (ER) of the liver of ovariectomized female rats after a single injection of 1, 25 and 500 micrograms of E2 were investigated using new variants of a method of ligand exchange. The ER content in liver cells was 12275 +/- 1100 (n = 33) bonds per cell (by one order lower than in the uterus). A single injection of E2 at a dose of 1 micrograms caused no changes in the ER content in the liver cytosol and nuclear fractions whereas reciprocal redistribution of ER between the cytosol and nuclei was noted in the uterus. A single injection of 25 and 500 micrograms of E2 to ovariectomized female rats resulted in dose dependent ER redistribution between the cytosol and nuclear fractions, the development of "deficiency" of the total ER content in liver cells was also dose dependent. The main regularities of the time course and intracellular distribution of ER in the liver of ovariectomized female rats after a single injection of large doses of E2 were similar to those in common target organs for estrogens.

Download full-text PDF

Source

Publication Analysis

Top Keywords

single injection
16
liver cells
12
ovariectomized female
12
female rats
12
content liver
12
regularities time
8
time course
8
course intracellular
8
intracellular distribution
8
liver ovariectomized
8

Similar Publications

Background: Herpes zoster (HZ) patients often experience herpes zoster-associated pain (ZAP). Thoracic paravertebral nerve block has been proven effective in relieving ZAP and reducing the incidence of postherpetic neuralgia (PHN). Compared to dexamethasone, dexamethasone palmitate (DXP) has stronger anti-inflammatory effects, a longer duration of action, and fewer adverse reactions.

View Article and Find Full Text PDF

Usher syndrome type 1C (USH1C) is a genetic disorder caused by mutations in the USH1C gene, which encodes harmonin, a key component of the mechanoelectrical transduction complex in auditory and vestibular hair cells. USH1C leads to deafness and vestibular dysfunction in humans. An Ush1c knockout (KO) mouse model displaying these characteristic deficits is generated in our laboratory.

View Article and Find Full Text PDF

Impact of blastocyst biopsy for preimplantation genetic testing on maternal and neonatal outcomes following single frozen embryo transfer cycles.

BMC Pregnancy Childbirth

January 2025

Assisted Reproduction Center, Northwest Women's and Children's Hospital, No. 73 Houzai Gate, Xincheng District, Xi'an, 710003, Shaanxi province, People's Republic of China.

Background: Up to now, a number of studies have explored the influence of blastocyst biopsy on maternal and neonatal outcomes, and the results have been somewhat inconsistent. Therefore, the aim of this study was to investigate whether blastocyst biopsy is associated with an elevated risk of hypertensive disorders of pregnancy (HDP) and other adverse perinatal outcomes during frozen embryo transfer (FET) cycles in singleton live births resulting from intracytoplasmic sperm injection (ICSI) in women aged ≤ 35 years.

Methods: A total of 1,008 women were involved in this study from January 2020 to June 2022, who underwent ICSI cycles and received single FET, leading to the birth of a live singleton newborn.

View Article and Find Full Text PDF

Objectives: The aim of this prospective study was to assess the association between methylene blue staining pattern and the presence of histologic nodal metastasis in dogs with low-grade mast cell tumour in low-resource settings for the efficient diagnosis of lymphatic spread.

Methods: Dogs with a single, cytologically low-grade mast cell tumour and no documented distant metastases were prospectively included and underwent surgery. Along with primary mast cell tumour removal, intraoperative sentinel lymph node mapping with peritumoral mast cell tumour injection and regional lymph node excision, regardless of whether blue dye was visible in the lymph node, were performed.

View Article and Find Full Text PDF

Introduction: In recent years, intravitreal injections (IVT) of vascular endothelial growth factor (VEGF) inhibitors have become the standard of care for several macular disorders. Frequently, the therapeutic course requires numerous injections, posing a burden on patients. Non-adherence to treatment may result in reduced visual outcomes, therefore understanding and addressing the underlying causes is imperative.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!